Funakoshi S - Search Results

1

Differential in vitro and in vivo antitumor effects mediated by anti-CD40 and anti-CD20 monoclonal antibodies against human B-cell lymphomas.

Funakoshi S, Longo DL, Murphy WJ. Funakoshi S, et al. J Immunother Emphasis Tumor Immunol. 1996 Mar;19(2):93-101. doi: 10.1097/00002371-199603000-00002. J Immunother Emphasis Tumor Immunol. 1996. PMID: 8732692

2

Activation-induced cell death of aggressive histology lymphomas by CD40 stimulation: induction of bax.

Szocinski JL, Khaled AR, Hixon J, Halverson D, Funakoshi S, Fanslow WC, Boyd A, Taub DD, Durum SK, Siegall CB, Longo DL, Murphy WJ. Szocinski JL, et al. Among authors: funakoshi s. Blood. 2002 Jul 1;100(1):217-23. doi: 10.1182/blood.v100.1.217. Blood. 2002. PMID: 12070030 Free article.

3

Inhibition of human B-cell lymphoma growth by CD40 stimulation.

Funakoshi S, Longo DL, Beckwith M, Conley DK, Tsarfaty G, Tsarfaty I, Armitage RJ, Fanslow WC, Spriggs MK, Murphy WJ. Funakoshi S, et al. Blood. 1994 May 15;83(10):2787-94. Blood. 1994. PMID: 7514045 Free article.

4

Antibodies to CD40 prevent Epstein-Barr virus-mediated human B-cell lymphomagenesis in severe combined immune deficient mice given human peripheral blood lymphocytes.

Murphy WJ, Funakoshi S, Beckwith M, Rushing SE, Conley DK, Armitage RJ, Fanslow WC, Rager HC, Taub DD, Ruscetti FW, et al. Murphy WJ, et al. Among authors: funakoshi s. Blood. 1995 Sep 1;86(5):1946-53. Blood. 1995. PMID: 7544649 Free article.

5

In vivo antitumor effects of unconjugated CD30 monoclonal antibodies on human anaplastic large-cell lymphoma xenografts.

Tian ZG, Longo DL, Funakoshi S, Asai O, Ferris DK, Widmer M, Murphy WJ. Tian ZG, et al. Among authors: funakoshi s. Cancer Res. 1995 Nov 15;55(22):5335-41. Cancer Res. 1995. PMID: 7585597

6

Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: role for transforming growth factor beta.

Turley JM, Funakoshi S, Ruscetti FW, Kasper J, Murphy WJ, Longo DL, Birchenall-Roberts MC. Turley JM, et al. Among authors: funakoshi s. Cell Growth Differ. 1995 Jun;6(6):655-63. Cell Growth Differ. 1995. PMID: 7669719

7

Epstein-Barr virus-induced human B-cell lymphoma arising in HuPBL-SCID chimeric mice: characterization and the role of CD40 stimulation in their treatment and prevention.

Funakoshi S, Beckwith M, Fanslow W, Longo DL, Murphy WJ. Funakoshi S, et al. Pathobiology. 1995;63(3):133-42. doi: 10.1159/000163944. Pathobiology. 1995. PMID: 8821629

8

Immunologic and hematopoietic effects of CD40 stimulation after syngeneic bone marrow transplantation in mice.

Funakoshi S, Taub DD, Anver MR, Raziuddin A, Asai O, Reddy V, Rager H, Fanslow WC, Longo DL, Murphy WJ. Funakoshi S, et al. J Clin Invest. 1997 Feb 1;99(3):484-91. doi: 10.1172/JCI119183. J Clin Invest. 1997. PMID: 9022082 Free PMC article.

9

Antitumor effects of nonconjugated murine Lym-2 and human-mouse chimeric CLL-1 monoclonal antibodies against various human lymphoma cell lines in vitro and in vivo.

Funakoshi S, Hirano A, Beckwith M, Asai O, Jorgensen G, Tian Z, Hornick JL, Hu P, Khawli LA, Epstein AL, Longo DL, Murphy WJ. Funakoshi S, et al. Blood. 1997 Oct 15;90(8):3160-6. Blood. 1997. PMID: 9376598 Free article.

10

CD40 stimulation promotes human secondary immunoglobulin responses in HuPBL-SCID chimeras.

Murphy WJ, Funakoshi S, Fanslow WC, Rager HC, Taub DD, Longo DL. Murphy WJ, et al. Among authors: funakoshi s. Clin Immunol. 1999 Jan;90(1):22-7. doi: 10.1006/clim.1998.4632. Clin Immunol. 1999. PMID: 9884349

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

298 results

Search Page

Filters